Kyverna Therapeutics Company
Kyverna Therapeutics is pioneering a new class of therapies and cures for serious autoimmune diseases.
Technology:
Cell therapy, Cell-based gene therapy
Industry:
Private
Headquarters:
Berkeley, California, United States
Founded Date:
2018-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
13
Total Funding:
110000000
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-01-26
Last Funding Type:
Series B
Register and Claim Ownership